Implementation of a patient education program on multiple sclerosis relapse management

Patient Education and Counseling

Volumn 86, Issue 1, 2012, Pages 91-97

  Köpke, Sascha ^a,b   Richter, Tanja ^b   Kasper, Jürgen ^a,b   Mühlhauser, Ingrid ^b   Flachenecker, Peter ^c   Heesen, Christoph ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c Neurological Rehabilitation Center Quellenhof   (Germany)

Author keywords

Decision support system; Evidence based medicine; Glucocorticoids; Implementation study; Multiple sclerosis; Patient autonomy; Patient education as topic; Patient information; Relapse; Uncertainty

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; EDUCATION PROGRAM; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MULTIPLE SCLEROSIS; PATIENT AUTONOMY; PATIENT CARE; PATIENT EDUCATION; PATIENT PREFERENCE; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SHARED DECISION MAKING; UNCERTAINTY;

DECISION SUPPORT TECHNIQUES; EDUCATIONAL STATUS; EVIDENCE-BASED MEDICINE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MULTIPLE SCLEROSIS; PATIENT EDUCATION AS TOPIC; PERSONAL AUTONOMY; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PSYCHOMETRICS; QUESTIONNAIRES; RECURRENCE; RISK ASSESSMENT; UNCERTAINTY;

EID: 83655165369     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2011.03.013     Document Type: Article

References (31)

1. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
2. Whiting P., Harbord R., Main C., Deeks J.J., Filippini G., Egger M., et al. Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review. Brit Med J 2006, 332:875-884.
3. Confavreux C., Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006, 129:606-616.
4. Fisniku L.K., Brex P.A., Altmann D.R., Miszkiel K.A., Benton C.E., Lanyon R., et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008, 131:808-817.
5. The National Collaborating Centre for Chronic Conditions. Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care; 2004. Online document: [accessed 14.02.11]. http://www.nice.org.uk/nicemedia/live/10930/46699/46699.pdf.
6. Ramsaransing G.S., De Keyser J. Benign course in multiple sclerosis: a review. Acta Neurol Scand 2006, 113:359-369.
7. European MS Platform. European Code of Good Practice on the rights and quality of life of people affected by multiple sclerosis; 2008. Online document: [accessed 14.02.11]. http://www.ms-in-europe.com/w3p_dokumentearchiv/1code08.pdf.
8. Giordano A., Mattarozzi K., Pucci E., Leone M., Casini F., Collimedaglia L., et al. Participation in medical decision-making: attitudes of Italians with multiple sclerosis. J Neurol Sci 2008, 275:86-91.
9. Solari A., Acquarone N., Pucci E., Martinelli V., Marrosu M.G., Trojano M., et al. Communicating the diagnosis of multiple sclerosis - a qualitative study. Mult Scler 2007, 13:763-769.
10. Giordano A., Uccelli M.M., Pucci E., Martinelli V., Borreani C., Lugaresi A., et al. The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients. Mult Scler 2009, 16:100-111.
11. Heesen C., Kasper J., Segal J., Köpke S., Mühlhauser I. Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis. Mult Scler 2004, 10:643-650.
12. Heesen C., Kolbeck J., Gold S.M., Schulz H., Schulz K.H. Delivering the diagnosis of MS - results of a survey among patients and neurologists. Acta Neurol Scand 2003, 107:363-368.
13. Vickrey B.G., Shatin D., Wolf S.M., Myers L.W., Belin T.R., Hanson R.A., et al. Management of multiple sclerosis across managed care and fee-for-service systems. Neurology 2000, 55:1341-1349.
14. Wollin J.D.H., Spenser N., Walsh A. What people with newly diagnosed MS (and their families and friends) need to know. Int J MS Care 2000, 2:4-14.
15. Charles C., Whelan T., Gafni A. What do we mean by partnership in making decisions about treatment?. Brit Med J 1999, 319:780-782.
16. Kasper J., Kopke S., Muhlhauser I., Heesen C. Evidence-based patient information about treatment of multiple sclerosis - a phase one study on comprehension and emotional responses. Patient Educ Couns 2006, 62:56-63.
17. Kasper J., Köpke S., Mühlhauser I., Nübling M., Heesen C. Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): a randomized controlled trial. Eur J Neurol 2008, 15:1345-1352.
18. Köpke S., Kasper J., Mühlhauser I., Nübling M., Heesen C. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial. Mult Scler 2009, 15:96-104.
19. Rieckmann P., Toyka K.V., Bassetti C., Beer K., Beer S., Buettner U., et al. Escalating immunotherapy of multiple sclerosis - new aspects and practical application. J Neurol 2004, 251:1329-1339.
20. Filippini G., Brusaferri F., Sibley W., Citterio A., Ciucci G., Midgard R., et al. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database Syst Rev 2000, CD001331.
21. Köpke S., Heesen C., Kasper J., Mühlhauser I. Steroid treatment for relapses in multiple sclerosis - the evidence urges shared decision-making. Acta Neurol Scand 2004, 110:1-5.
22. Burton J.M., O'Connor P.W., Hohol M., Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst Rev 2009, CD006921.
23. Martinelli V., Rocca M.A., Annovazzi P., Pulizzi A., Rodegher M., Boneschi F.M., et al. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS. Neurology 2009, 73:1842-1848.
24. Mühlhauser I., Berger M. Patient education - evaluation of a complex intervention. Diabetologia 2002, 45:1723-1733.
25. Degner L.F., Sloan J.A., Venkatesh P. The control preferences scale. Can J Nurs Res 1997, 29:21-43.
26. Bero L.A., Grilli R., Grimshaw J.M., Harvey E., Oxman A.D., Thomson M.A. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. Brit Med J 1998, 317:465-468.
27. Woolf S.H. The meaning of translational research why it matters. J Amer Med Assoc 2008, 299:211-213.
28. Eccles M.P., Armstrong D., Baker R., Cleary K., Davies H., Davies S., et al. An implementation research agenda. Implement Sci 2009, 4:18.
29. Boeije H.R., Janssens A.C. 'It might happen or it might not': how patients with multiple sclerosis explain their perception of prognostic risk. Soc Sci Med 2004, 59:861-868.
30. Küver C., Beyer M., Gensichen J., Ludt S., Schmitz A., Szecsenyi J., et al. An assessment of patient education programmes for patients with type 1 and 2 diabetes, asthma and COPD, coronary heart disease, hypertension, congestive heart failure, and breast cancer in Germany. Z Arztl Fortbild Qualitatssich 2004, 98:393-402.
31. Heesen C., Köpke S., Hauptmann B., Henze T. Rehabilitation bei Multipler Sklerose in Deutschland - Ergebnisse einer Umfrage. Aktuel Neurol 2010, 37:1-6.